Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Azonaire Hayfever & Allergy Prevention & Relief |
Active Ingredient: | Mometasone furoate monohydrate 0.5mg/g |
Dosage Form: | Nasal spray suspension |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Lek Pharmaceuticals d.d., Ljubljana, Slovenia |
Product: | Ibuprofen (Multichem) |
Active Ingredient: | Ibuprofen 200mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Multichem NZ Limited |
Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
Product: | Picoprep Orange |
Active Ingredients: | Citric acid 12.2g Magnesium carbonate monohydrate 7.4g Sodium picosulfate 10.3mg |
Dosage Form: | Powder for oral solution |
New Zealand Sponsor: | Fresenius Kabi New Zealand Limited |
Manufacturer: | Probiotec Pharma Pty Limited, Melbourne, Australia |
Product: | Symbicort Rapihaler 100/3 |
Active Ingredients: | Budesonide 80mcg Formoterol fumarate 2.25mcg |
Dosage Form: | Aerosol inhaler, metered dose |
New Zealand Sponsor: | AstraZeneca Limited |
Manufacturer: | AstraZeneca Dunkerque Production SCS, Dunkerque, France |
Product: | Valproate-AFT |
Active Ingredient: | Sodium valproate 100mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | AFT Pharmaceuticals Limited |
Manufacturer: | Labiana Pharmaceuticals S.L.U., Barcelona, Spain |
Dated this 13th day of December 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).